A phase 1b study of once-weekly carfilzomib combined with lenalido-mide and dexamethasone (wKRd) in patients (pts) with newly diagnosed multiple myeloma (NDMM) Meeting Abstract


Authors: Alsina, M.; Landgren, C. O.; Raje, N.; Niesvizky, R.; Bensinger, W. I.; Berdeja, J.; Kovacsovics, T.; Vesole, D.; Fang, B.; Kimball, A.; Siegel, D. S.
Abstract Title: A phase 1b study of once-weekly carfilzomib combined with lenalido-mide and dexamethasone (wKRd) in patients (pts) with newly diagnosed multiple myeloma (NDMM)
Meeting Title: 17th International Myeloma Workshop
Keywords: carfilzomib; newly diagnosed multiple myeloma; once-weekly
Journal Title: Clinical Lymphoma, Myeloma and Leukemia
Volume: 19
Issue: 10 Suppl.
Meeting Dates: 2019 Sept 12-15
Meeting Location: Boston, MA
ISSN: 2152-2650
Publisher: Elsevier Inc.  
Date Published: 2019-10-01
Start Page: e52
Language: English
ACCESSION: WOS:000491229800079
DOI: 10.1016/j.clml.2019.09.079
PROVIDER: wos
Notes: Meeting Abstract: OAB-078 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Carl Ola Landgren
    336 Landgren